Esfenvalerate のラット, マウスでの代謝および他の異性体の esfenvalerate の代謝に対する影響

  • 磯部 直彦
    Biochemistry and Toxicology Laboratory, Sumitomo Chemical Co., Ltd.
  • 金子 秀雄
    Biochemistry and Toxicology Laboratory, Sumitomo Chemical Co., Ltd.
  • 斯波 久二雄
    Biochemistry and Toxicology Laboratory, Sumitomo Chemical Co., Ltd.
  • 斎藤 幸一
    Biochemistry and Toxicology Laboratory, Sumitomo Chemical Co., Ltd.
  • 井藤 重美
    Biochemistry and Toxicology Laboratory, Sumitomo Chemical Co., Ltd.
  • 角田 紀子
    Biochemistry and Toxicology Laboratory, Sumitomo Chemical Co., Ltd.
  • 斎藤 亜矢子
    Biochemistry and Toxicology Laboratory, Sumitomo Chemical Co., Ltd.
  • 吉武 彬
    Biochemistry and Toxicology Laboratory, Sumitomo Chemical Co., Ltd.
  • 宮本 純之
    Biochemistry and Toxicology Laboratory, Sumitomo Chemical Co., Ltd.

書誌事項

タイトル別名
  • Metabolism of Esfenvalerate in Rats and Mice and Effects of Its Isomers on Metabolic Fates of Esfenvalerate
  • Esfenvalerateのラット,マウスでの代謝および他の異性体のesfenvalerateの代謝に対する影響〔英文〕
  • Esfenvalerate ノ ラット マウス デ ノ タイシャ オヨビ タ

この論文をさがす

説明

On single or repeated oral administration of 14C-labeled esfenvalerate [(S)-α-cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl) isovalerate] to male and female rats and mice at 2.5mg/kg or 2.5mg/kg/day for successive 10 days, radiocarbon was rapidly and almost completely excreted into the urine and feces. 14C tissue residues after single oral administration were generally very low except for in the fat in both rats and mice. Major biotransformation reactions were 1) oxidation at the 2- and 3-positions of the acid moiety and the 2′- and 4′-phenoxy positions of the alcohol moiety, 2) cleavage of ester linkage, and 3) conjugation of the resultant carboxylic acids, alcohols and phenols with glucuronic acid, sulfuric acid, glycine or taurine. Treatment of rats and mice with single or repeated oral doses of a mixture of 14C-esfenvalerate and unlabeled [2S, αR]-, [2R, αS]- and [2R, αR]-isomers of fenvalerate [(RS)-α-cyano-3-phenoxybenzyl (RS)-2-(4-chlorophenyl) isovalerate] at the equal ratio revealed that the unlabeled isomers added hardly affected 14C excretion profiles, 14C tissue residues and amounts of metabolites of esfenvalerate, indicating that esfenvalerate behaved independently of other isomers. There were no significant differences in metabolic fates between esfenvalerate and fenvalerate except that 14C fenvalerate labeled in the acid moiety showed slightly higher 14C tissue residues than esfenvalerate, due to formation of cholesteryl (R)-2-(4-chlorophenyl) isovalerate from fenvalerate but not from esfenvalerate.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ